Big Pharma has become a familiar whipping boy in the debate over healthcare costs. CAR-T therapies to treat certain cancers, for example, can cost between half a million and a million dollars for a single treatment course. What’s the prospect of a cancer cure worth to you?GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are transforming the lives of obese patients. For most people, these drugs will have...
Read More »Are Drug Companies Alone Responsible for the Prices We Pay for Medicines?
I had presented Part I and Part II a while back. Part III was difficult to present in a piece-meal way so for now I have set it aside. What is interesting about Part IV is I can beak it apart into segments, still maintain the flow of informatio, and present it in a logical manner. Bear with me. By the time we get to the end, I believe you will be able to piece this together too. In Part IV . . . What Antonio is doing in Part IV is laying the...
Read More »Ten Drugs Medicare Will Negotiate New Drug Pricing
Or a Tale of two Pricings for the Same Drug, One for the US and another for other countries. Eventually Medicare is going to get around to negotiating with these ten companies for the ten drugs in question here. As taken from one section of Lever News, I have reposted the finding of those ten drugs. What you will see is the pricing for the United States as compared to the pricing in other countries. I do not believe many people are aware of how...
Read More »China Goes Generic! — Dean Baker
Must-read. It's short.Not only does this have a potentially huge impact on Big Pharma, but it is also China poking the US in the eye in retaliation for it regards as humiliation. So it is also "saving face."Perhaps the largest and longest lasting impact of the trade war that is already occurring is the change in attitude of Chinese consumers about American products. The Chinese are very nationalistic and patriotic. They are also ethnically proud and justifiably so based on being able to...
Read More »